Ally Bridge Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Ally Bridge Group’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-240,892	Closed	-$8.03M	–	38
2024 Q3	$8.03M	Buy	240,892 +21,911	+10%	+$754K	4.3%	8
2024 Q2	$5.92M	Sell	218,981 -51,578	-19%	-$1.02M	3.53%	16
2024 Q1	$5.84M	Buy	+270,559	New	+$5.9M	3.25%	17

Ally Bridge Group's LBPH Position: Q4 2024 in Review

Ally Bridge Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 240,892 shares — an estimated $8.03M sold.

Ally Bridge Group first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $8.03M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Ally Bridge Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Ally Bridge Group sold 240,892 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $8.03M.
Ally Bridge Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Ally Bridge Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $8.03M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Ally Bridge Group's 13F filing for Q4 2024, filed 14 Feb 2025.